Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBTF
1501
DELISTED
MBT Financial Corporation
MBTF
| $6.52M | 0.01% |
574,714
+84,267
| +17% | +$820K |
|
|
BID
1502
DELISTED
Sotheby's
BID
| $6.52M | 0.01% |
+163,500
| New | +$6.2M |
|
1503
Genworth Financial
GNW
$3.84B
| $6.51M | 0.01% |
1,708,700
+956,132
| +127% | +$4.21M |
|
1504
Unifirst Corp
UNF
$5.19B
| $6.51M | 0.01% |
45,300
-46,800
| -51% | -$6.34M |
|
|
ATSG
1505
DELISTED
Air Transport Services Group
ATSG
| $6.48M | 0.01% |
406,000
+103,600
| +34% | +$1.6M |
|
|
CTB
1506
DELISTED
Cooper Tire & Rubber Co.
CTB
| $6.47M | 0.01% |
+166,600
| New | +$6.27M |
|
|
FDML
1507
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $6.47M | 0.01% |
627,730
+143,800
| +30% | +$1.4M |
|
1508
Monarch Casino & Resort
MCRI
$2.22B
| $6.46M | 0.01% |
250,520
+67,120
| +37% | +$1.66M |
|
|
EMCI
1509
DELISTED
EMC INS Group Inc
EMCI
| $6.45M | 0.01% |
214,950
+1,200
| +0.6% | +$33K |
|
|
OMCC
1510
DELISTED
Old Market Capital Corp
OMCC
| $6.43M | 0.01% |
541,229
+26,000
| +5% | +$263K |
|
|
BPY
1511
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $6.41M | 0.01% |
292,242
+154,828
| +113% | +$3.38M |
|
|
AIMC
1512
DELISTED
Altra Industrial Motion Corp
AIMC
| $6.39M | 0.01% |
173,200
-40,000
| -19% | -$1.33M |
|
1513
TD Synnex
SNX
$20.7B
| $6.39M | 0.01% |
105,600
-101,200
| -49% | -$5.74M |
|
1514
Thomson Reuters
TRI
$44.9B
| $6.38M | 0.01% |
125,722
+80,138
| +176% | +$3.91M |
|
|
XHR
1515
Xenia Hotels & Resorts
XHR
$1.77B
| $6.38M | 0.01% |
328,500
+16,700
| +5% | +$285K |
|
|
ZPIN
1516
DELISTED
Zhaopin Limited
ZPIN
| $6.36M | 0.01% |
420,600
+68,600
| +19% | +$1.02M |
|
|
APEX
1517
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $6.35M | 0.01% |
20,168
+1,042
| +5% | +$327K |
|
|
NPTN
1518
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.34M | 0.01% |
586,600
-273,400
| -32% | -$3.65M |
|
1519
CNB Financial Corp
CCNE
$1.03B
| $6.33M | 0.01% |
236,900
+55,573
| +31% | +$1.27M |
|
|
REGI
1520
DELISTED
Renewable Energy Group, Inc.
REGI
| $6.32M | 0.01% |
651,027
+318,466
| +96% | +$2.98M |
|
|
CEQP
1521
DELISTED
Crestwood Equity Partners LP
CEQP
| $6.3M | 0.01% |
246,582
+84,300
| +52% | +$1.84M |
|
1522
Bar Harbor Bankshares
BHB
$681M
| $6.27M | 0.01% |
198,600
+40,050
| +25% | +$1.11M |
|
1523
Cabot Corp
CBT
$4.54B
| $6.24M | 0.01% |
123,500
-84,700
| -41% | -$4.36M |
|
1524
Commercial Vehicle Group
CVGI
$132M
| $6.23M | 0.01% |
1,127,206
+227,606
| +25% | +$1.21M |
|
|
ESSA
1525
DELISTED
ESSA Bancorp
ESSA
| $6.23M | 0.01% |
396,300
+55,300
| +16% | +$815K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.